The TCERG1L gene, a paralog of TCERG1, is a transcription elongation regulator that has been described to be involved in the pathogenesis of cancer and non-cancer-related diseases, but it has not previously been associated with chemotherapy-induced hearing loss. Here, TCERG1L is linked to cancer.